Hibbett Inc Com (NASDAQ:HIBB) Stock, Quote.Headers.trade-ideas

Hibbett

Hibbett Sports

HIBB, Hibbett

Earnings

Equities

News

Guidance

Markets

Movers

General

HIBB

JDSPY

Hibbett shares decline in premarket trading as the company misses Q1 earnings expectations and reports a drop in revenues and comparable sales.

Merger-Bound Athletic-Inspired Fashion Retailer Hibbett Stumbles In Q1: Details

Futures

Previews

Economics

Federal Reserve

Pre-Market Outlook

Trading Ideas

$BTC

CHPT

CRWD

DLTR

FIVE

LULU

OLLI

SFIX

SMAR

SMTC

UNFI

VSCO

U.S. stocks are gearing up for a cautiously optimistic start on Wednesday after a late-session recovery led to a positive close in the previous session.

Wall Street Looks To Extend Gains As Traders Eye More Jobs Data: Why This Analyst Sees 4% S&amp;P 500 Rise In June

Stock Market

Eurozone

Commodities

Intraday Update

ABEO

JBLU

OPRT

PALI

Crude Oil Moves Higher; General Motors Earnings Top Views

Hibbett Inc Com

Telsey Advisory Group analyst Cristina Fernandez maintains Hibbett Inc Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) with a Market Perform and maintains $87.5 price target.

Price Target

Analyst Ratings

Telsey Advisory Group Maintains Market Perform on Hibbett Inc Com, Maintains $87.5 Price Target

JD Sports Fashion Plc (XLON: JD) is acquiring Hibbett in a deal expected to close soon pending final closing conditions.&nbsp;

QDEL

QuidelOrtho To Replace Hibbett In S&P SmallCap 600, Effective Prior To Opening Of Trading On July 26

Telsey Advisory Group analyst Cristina Fernandez maintains Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) with a Market Perform and maintains $87.5 price target.

Telsey Advisory Group Maintains Market Perform on Hibbett, Maintains $87.5 Price Target

Hibbett, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) reported first-quarter fiscal 2025 earnings per share of $2.67, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/06/b39179401/hibbett-reports-first-quarter-fiscal-2025-results" rel="noreferrer noopener">missing the street view of $2.70.</a>
Hibbett registered quarterly revenues of $447.16 million, <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">missing the analyst consensus of $453.91 million</a>. Net sales fell 1.8% year over year.
Comparable sales decreased 5.8% year over year. Brick-and-mortar comparable sales declined 5.8%, while e-commerce sales also decreased 5.8% year over year.
Gross margin was 35.8% of net sales in the first quarter, compared with 33.7% a year ago.
The approximate 210-basis-point increase was driven primarily by higher average product margin, which was approximately 195 basis points favorable to the prior-year period. The improved product margin resulted from a lower promotional and clearance environment.&nbsp;
In the first quarter, the company opened six stores and closed six stores, leaving the store base unchanged from the prior quarter at 1,169 in 36 states.
As of May 4, the company had $28.7 million of available cash and equivalents on an unaudited condensed consolidated balance sheet and $7.5 million of debt outstanding on a $160 million unsecured line of credit.
Inventory was $371.3 million at the end of the first quarter, a 15.2% decrease compared to the prior year&#8217;s first quarter and up 7.8% from the beginning of the fiscal year.
Guidance Withdrawn: On April 23, Hibbett entered into a <a target="_blank" href="https://www.benzinga.com//node/38374258" rel="noreferrer noopener">definitive agreement to be acquired </a>by a subsidiary of JD Sports Fashion PLC (OTC:<a class="ticker" href="https://www.benzinga.com/stock/JDSPY#OTC">JDSPY</a>).
In light of the pending transaction, Hibbett said it will not be hosting an earnings conference call to discuss its results for the first quarter, and will not be providing or <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">updating previously issued financial guidance.</a>
Price Action: HIBB shares are trading lower by 0.31% to $86.00 premarket at last check Wednesday.
Read Next:<a href="https://www.benzinga.com/markets/equities/24/06/39167512/united-airlines-hits-brakes-on-hiring-this-year-due-to-boeing-woes-report" target="_blank" rel="noreferrer noopener"> United Airlines Hits Brakes On Hiring This Year Due To Boeing Woes: Report</a>
Photo via Wikimedia Commons

U.S. stocks are gearing up for a cautiously optimistic start on Wednesday after<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39166415/stocks-dip-even-with-traders-hopeful-for-september-rate-cut-bonds-extend-rally-oil-plummet"> a late-session recovery led to a positive close </a>in the previous session. Labor market data and service sector activity reading could set the tempo for the day&#8217;s trading direction. A soft private payroll number could prove to be a double-edged sword, depending on what traders choose to focus on. Bond yields remain subdued and but could see some volatility post the data. Positive reactions to earnings, specifically from the tech sector, could provide a lift to the space.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.39%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>+0.20%</td>
</tr>
<tr>
<td>Dow</td>
<td>+0.13%</td>
</tr>
<tr>
<td>R2K</td>
<td>+0.05%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption"> In premarket trading on Wednesday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) slumped 0.20% to $529.44, and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) traded up 0.42% at $456.21, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.</figcaption></figure>
Cues From Previous Session:
U.S. stocks moved about in a lackluster manner for the bulk of Tuesday&#8217;s session but managed to close the day higher. After the Labor Department&#8217;s JOLTS survey, showing job openings slumping to their lowest level since 2021 jolted the market early on, the indices stayed mostly below the unchanged. Stocks experienced volatility in the late session but came back up to end firmer.
Small-cap stocks ended with notable losses amid the meme stock volatility.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+0.17%</td>
<td>16,857.05</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>+0.15%</td>
<td>5,291.34</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>+0.36%</td>
<td>38,711.29</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.25%</td>
<td>2,033.94</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Fund Strat&#8217;s Tom Lee expects the S&amp;P 500 Index to gain 4% to 5,500 in June, premised on softening inflation, and softening but not weakening labor market. In an interview with CNBC, he<a href="https://x.com/SquawkCNBC/status/1798013799737237905"> said</a> the sell-off in April hasn&#8217;t been really recovered. Also, there is $6 trillion in cash waiting on the sidelines that could be deployed by traders, he added.
Fund manager Louis Navellier said in a note to clients that June is typically a very positive month for small and mid-capitalization stocks that are added to Russell indices.&nbsp; This potentially could help broaden the market rally.
He noted that Russell typically publishes their proposed changes on the first Friday in June and then it refines their proposed index changes for two additional weeks.&nbsp;&#8220;As Russell adds some&nbsp;stocks to their Russell 1000 and 2000 indices, those stocks typically "pop" on institutional buying pressure,&#8221; he added.
Upcoming Economic Data:
<ul>
<li>ADP is scheduled to release its private payrolls report at 8:15 a.m. EDT. Economists, on average, expect private payroll gains of 175,000 in May, down from 192,000 in April.</li>
<li>The final S&amp;P Global U.S. services sector purchasing managers&#8217; index, due at 9:45 a.m. EDT, is expected to show a reading of 54.8 for May, up from 51.3 in April.</li>
<li>The Institute for Supply Management&#8217;s non-manufacturing index for May will be released at 10 a.m. EDT. The PMI may have increased from 49.4 in April to 50.7 in May.</li>
<li>The Energy Information Administration is scheduled to release its customary weekly petroleum status report at 10:30 a.m. EDT.</li>
</ul>
See Also: <a href="https://www.benzinga.com/money/best-futures-trading-platforms">9 Best Futures Trading Platforms in 2024</a>
Stocks In Focus:
<ul>
<li> Hewlett Packard Enterprise Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) climbed over 14% in premarket trading following the company&#8217;s quarterly results announcement, and CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) rose over 8%.</li>
<li>Stitch Fix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFIX#NASDAQ">SFIX</a>) soared more than 17%, also on earnings.</li>
<li>Campbell Soup Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NYSE">CPB</a>), Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>), Ollie&#8217;s Bargain Outlet Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>), Hibbett, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) and United Natural Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) are among the notable companies reporting their quarterly results before the market open.</li>
<li>Those reporting after the close include ChargePoint Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>), Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>), Victoria&#8217;s Secret &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>), Five Below, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>), Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) and Smartsheet Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>).</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil and gold futures rose modestly and the 10-year U.S. Treasury note yield edged up to 4.342%. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) climbed over 2% over the past 24 hours and was closing in on the $71K level.
While Asian stocks closed mixed, the major European markets firmed up in early trading. The Indian market rebounded after Tuesday&#8217;s sell-off amid the 2024 general election results, and the Japanese, Hong Kong, and Chinese markets settled lower.
Read Next: <a href="https://www.benzinga.com/markets/equities/24/06/39176944/bye-bye-nyse-nasdaq-wall-street-bigwigs-blackrock-citadel-lead-charge-for-new-apolitical-ceo-fri">Bye-Bye NYSE, Nasdaq? Wall Street Bigwigs BlackRock, Citadel Lead Charge For New &#8216;Apolitical,&#8217; &#8216;CEO-Friendly&#8217; Stock Exchange In Texas</a>
Image Via Shutterstock

Wall Street Looks To Extend Gains As Traders Eye More Jobs Data: Why This Analyst Sees 4% S&P 500 Rise In June

Hibbett Says Q1 Comparable Sales Decreased 5.8% YoY; Net Sales Fell 1.8% YoY

Hibbett Says In Light Of Pending Transaction With JD Sports, Company Will Not Host An Earnings Conference Call And Will Not Provide Or Update Previously Issued Financial Guidance

Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) reported quarterly earnings of $2.67 per share. This is a 2.55 percent decrease over earnings of $2.74 per share from the same period last year. The company reported quarterly sales of $447.16 million which missed the analyst consensus estimate of $453.42 million by 1.38 percent. This is a 1.83 percent decrease over sales of $455.50 million the same period last year.

Earnings Beats

Earnings Misses

Hibbett Q1 EPS $2.67 Misses $2.70 Estimate, Sales $447.16M Miss $453.42M Estimate

In the latest quarter, 10 analysts provided ratings for Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>), showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Hibbett, revealing an average target of $81.9, a high estimate of $88.00, and a low estimate of $70.00. Surpassing the previous average price target of $75.39, the current average has increased by 8.64%.
<img src="https://www.benzinga.com/files/images/story/2024/1717419614_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of Hibbett by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$87.50</td>
<td>$87.50</td>
</tr>
<tr>
<td>Peter Benedict</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$87.50</td>
<td>$80.00</td>
</tr>
<tr>
<td>Anna Glaessgen</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$87.50</td>
<td>$70.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$87.50</td>
<td>$74.00</td>
</tr>
<tr>
<td>Anna Glaessgen</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Sam Poser</td>
<td>Williams Trading</td>
<td>Announces</td>
<td>Hold</td>
<td>$73.00</td>
<td>-</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$74.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Mitch Kummetz</td>
<td>Seaport Global</td>
<td>Raises</td>
<td>Buy</td>
<td>$88.00</td>
<td>$70.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Hibbett. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Hibbett compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Hibbett's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Hibbett's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HIBB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hibbett analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Hibbett's Background</h2>
Hibbett Inc is engaged in the retail of sports goods. The company operates small to midsize stores and focuses its business on the South, Southwest, mid-Atlantic, and Midwest areas of the country. It offers a broad range of sporting goods, including apparel, footwear, accessories, and equipment needed for team sports, with brands such as Nike, Under Armour, Adidas, The North Face, Jordan, Costa, and others. The company consists of three kinds of stores: Hibbett Sports, the company's primary retail format stores, accounting for most of the company's total stores, and City Gear, and Sports Additions, smaller-format stores primarily offering athletic footwear with a fashion-based style.
<h3>Hibbett: Delving into Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Hibbett displayed positive results in 3 months. As of 31 January, 2024, the company achieved a solid revenue growth rate of approximately 1.81%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Hibbett's net margin is impressive, surpassing industry averages. With a net margin of 6.62%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Hibbett's ROE excels beyond industry benchmarks, reaching 7.64%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.32%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.87, Hibbett adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Hibbett In The Eyes Of 10 Experts

Baird analyst Peter Benedict downgrades Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) from Outperform to Neutral and raises the price target from $80 to $87.5.

Downgrades

Baird Downgrades Hibbett to Neutral, Raises Price Target to $87.5

In the last three months, 8 analysts have published ratings on Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Hibbett, presenting an average target of $80.5, a high estimate of $88.00, and a low estimate of $70.00. Marking an increase of 10.27%, the current average surpasses the previous average price target of $73.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1713963654_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Hibbett. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anna Glaessgen</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$87.50</td>
<td>$70.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$87.50</td>
<td>$74.00</td>
</tr>
<tr>
<td>Anna Glaessgen</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Sam Poser</td>
<td>Williams Trading</td>
<td>Announces</td>
<td>Hold</td>
<td>$73.00</td>
<td>-</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$74.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Mitch Kummetz</td>
<td>Seaport Global</td>
<td>Raises</td>
<td>Buy</td>
<td>$88.00</td>
<td>$70.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Hibbett. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Hibbett compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Hibbett's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HIBB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hibbett analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Hibbett Better</h2>
Hibbett Inc is engaged in the retail of sports goods. The company operates small to midsize stores and focuses its business on the South, Southwest, mid-Atlantic, and Midwest areas of the country. It offers a broad range of sporting goods, including apparel, footwear, accessories, and equipment needed for team sports, with brands such as Nike, Under Armour, Adidas, The North Face, Jordan, Costa, and others. The company consists of three kinds of stores: Hibbett Sports, the company's primary retail format stores, accounting for most of the company's total stores, and City Gear, and Sports Additions, smaller-format stores primarily offering athletic footwear with a fashion-based style.
<h3>Financial Milestones: Hibbett's Journey</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Hibbett's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.81% as of 31 January, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Hibbett's net margin is impressive, surpassing industry averages. With a net margin of 6.62%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Hibbett's ROE excels beyond industry benchmarks, reaching 7.64%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Hibbett's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 3.32%, the company showcases efficient use of assets and strong financial health.
Debt Management: Hibbett's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.87.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Key Takeaways From Hibbett Analyst Ratings

B. Riley Securities analyst Anna Glaessgen maintains Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) with a Neutral and raises the price target from $70 to $87.5.

B. Riley Securities Maintains Neutral on Hibbett, Raises Price Target to $87.5

Benchmark analyst John Lawrence downgrades Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) from Buy to Hold.

Benchmark Downgrades Hibbett to Hold

U.S. stocks traded higher toward the end of trading, with the S&amp;P 500 gaining more than 1% on Tuesday.
The Dow traded up 0.68% to 38,499.41 while the NASDAQ rose 1.69% to 15,711.94. The S&amp;P 500 also rose, gaining, 1.24% to 5,072.91.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38376714/wall-streets-most-accurate-analysts-views-on-3-energy-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts&#8217; Views On 3 Energy Stocks With Over 3% Dividend Yields</a>
Leading and Lagging Sectors Communication services shares climbed by 2% on Tuesday.
In trading on Tuesday, materials shares fell by 0.5%.
Top Headline General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) reported better-than-expected earnings for its fiscal first quarter.
The company posted quarterly sales growth of 7.6% year-on-year to $43.01 billion, beating the analyst consensus estimate of $41.88 billion. Adjusted EPS of $2.62 beat the consensus estimate of $2.14.
General Motors projects adjusted EPS of $9.00 – $10.00 (prior $8.50 – $9.50) versus consensus of $9.08.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Hibbett, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) shares shot up 19% to $86.26 after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transaction.</li>
<li>Shares of Oportun Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRT#NASDAQ">OPRT</a>) got a boost, surging 36% to $3.0710 after the company announced preliminary first-quarter total revenue above estimates.</li>
<li>Palisade Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares were also up, gaining 31% to $6.48 after the company entered into a collaboration with Strand Life Sciences.</li>
</ul>
Equities Trading DOWN
<ul>
<li>JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) shares dropped 17% to $6.24 after the company reported first-quarter financial results and issued weak FY24 revenue outlook.</li>
<li>Shares of Abeona Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) were down 54% to $3.3950 after the company announced the FDA issued a Complete Response Letter in response to the company&#8217;s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.</li>
<li>LKQ Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) was down, falling 13% to $42.67 after the company reported a first-quarter earnings miss and cut its FY24 outlook.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38377428/over-10m-bet-on-this-healthcare-stock-check-out-these-4-stocks-insiders-are-buying">Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying</a>
Commodities In commodity news, oil traded up 1.8% to $83.36 while gold traded down 0.2% at $2,342.00.
Silver traded up 0.5% to $27.38 on Tuesday, while copper fell 0.9% to $4.4350.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 1.09%, London's FTSE 100 rose 0.26% while Spain's IBEX 35 Index climbed 1.70% The German DAX gained 1.55% French CAC 40 rose 0.81% while Italy's FTSE MIB Index jumped 1.89%.
The S&amp;P Global UK PMI composite index climbed to 54.0 in April from 52.8 in the previous month. The HCOB Eurozone composite PMI surged to 51.4 in April from 50.3 a month ago.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Japan's Nikkei 225 gaining 0.30%, Hong Kong's Hang Seng Index gaining 1.92%, China's Shanghai Composite falling 0.74% and India's S&amp;P BSE Sensex gaining 0.12%.
The annual inflation rate in Hong Kong fell to 2% in March from 2.1% in the prior month. The HSBC India Composite flash PMI climbed to 62.2 in April versus a final reading of 61.8 in the earlier month. The au Jibun Bank Japan Composite PMI rose to 52.6 in April compared to a final reading of 51.7 a month ago.
Economics
<ul>
<li>Sales of new single-family houses jumped 8.8% month-over-month to an annualized rate of 693,000 in March, compared to a revised 5.1% decline in February.</li>
<li>The S&amp;P Global services PMI fell to 50.9 in April, recording the weakest level in five months and missing market estimates of 52.</li>
<li>The S&amp;P Global composite PMI fell to 50.9 in April versus 52.1 a month ago.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/04/38376630/amazon-com-united-airlines-and-2-other-stocks-insiders-are-selling">Amazon.com, United Airlines And 2 Other Stocks Insiders Are Selling</a>

Shares of Nucor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) fell sharply during Tuesday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/news/earnings/24/04/38365860/nucor-shares-fall-after-worse-than-expected-q1-results">quarterly financial results</a>.
Nucor reported quarterly earnings of $3.46 per share which missed the analyst consensus estimate of $3.65. Quarterly sales came in at $8.14 billion, missing the analyst consensus estimate of $8.26 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Nucor shares tumbled 6.5% to $179.20 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Cyngn Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares jumped 100% to $0.2419 after the company announced that it has been chosen to supply its DriveMod Tuggers for industrial automation to John Deere&#8217;s operation in Dubuque, Iowa.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares climbed 50.4% to $0.0689 after falling 10% on Monday.</li>
<li>Oportun Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRT#NASDAQ">OPRT</a>) gained 46% to $3.29 after the company announced preliminary first-quarter total revenue above estimates.</li>
<li>Palisade Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares climbed 44.3% to $7.12 after the company entered a collaboration with Strand Life Sciences.</li>
<li>KULR Technology Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NASDAQ">KULR</a>) gained 27% to $0.5683 after the company announced it delivered on an immediate basis, a power cell battery deployment order for AI-enabled drone and advanced air mobility missions in Ukraine.</li>
<li>Smart for Life, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMFL#NASDAQ">SMFL</a>) climbed 20% to $5.22.</li>
<li>HWH International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) rose 19.5% to $1.5307 after declining 3% on Monday.</li>
<li>SolarMax Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMXT#NASDAQ">SMXT</a>) gained 18.7% to $9.49.</li>
<li>Hibbett, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) rose 18.4% to $85.85 after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transaction.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) gained 17.4% to $1.3499.</li>
<li>SolarMax Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMXT#NASDAQ">SMXT</a>) rose 15.5% to $9.24.</li>
<li>FuelCell Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCEL#NASDAQ">FCEL</a>) gained 15.5% to $0.9295.</li>
<li>Carmell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) climbed 15.2% to $2.20.</li>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) shares gained 15% to $0.2244 after the company announced new preclinical data will be presented at the American Society of Gene and Cell Therapy meeting.</li>
<li>Virgin Galactic Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NASDAQ">SPCE</a>) jumped 14.4% to $0.8603.</li>
<li>9F Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFU#NASDAQ">JFU</a>) rose 14.3% to $3.29.</li>
<li>Canaan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) gained 14% to $1.05. The company executives announced intentions to purchase at least $2 million of the company's common stock.</li>
<li>Cartesian Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) jumped 12.7% to $20.59 after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $39 price target.</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) gained 12.3% to $305.73 following first-quarter financial results.</li>
<li>Heron Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTX#NASDAQ">HRTX</a>) climbed 11.6% to $2.89 after Capital One initiated coverage on the stock with an Overweight rating and $6 price target.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) gained 9.4% to $6.05.</li>
<li>Ryder System, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) rose 9% to $118.82 following better-than-expected quarterly earnings.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) jumped 8.8% to $10.15.</li>
<li>HealthStream, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSTM#NASDAQ">HSTM</a>) surged 7.4% to $25.91 following upbeat quarterly results.</li>
<li>Cidara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) shares rose 7% to $0.55 following upbeat quarterly results.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) gained 6.2% to $62.20.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Abeona Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) fell 48.4% to $3.7950 after the company announced the FDA issued a Complete Response Letter in response to the company&#8217;s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) shares fell 44.6% to $0.0699. Greenwave Technology Solutions disclosed that it further strengthened its balance sheet by approximately $12 million.</li>
<li>Lichen China Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) fell 44.4% to $0.5450.</li>
<li>Tungray Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) shares declined 34.2% to $4.87 after gaining 24% on Monday.</li>
<li>Tian Ruixiang Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIRX#NASDAQ">TIRX</a>) fell 26.3% to $0.5091.</li>
<li>Moolec Science SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLEC#NASDAQ">MLEC</a>) fell 24.3% to $1.87. On April 22, Moolec Science said it received approval for its plant-grown animal proteins.</li>
<li>YY Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYGH#NASDAQ">YYGH</a>) fell 22.4% to $2.25 after tumbling over 27% on Monday. The company, last week, priced its IPO at $4 per share.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) dipped 19.7% to $2.0899.</li>
<li>Comstock Holding Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHCI#NASDAQ">CHCI</a>) declined 18.8% to $6.44.</li>
<li>SuperCom Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCB#NASDAQ">SPCB</a>) dipped 18% to $0.2369. SuperCom recently reported better-than-expected quarterly results.</li>
<li>JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) declined 16.2% to $6.29 after the company reported first-quarter financial results and issued worse-than-expected Q2 and FY24 Revenue outlook.</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) declined 13% to $448.01 following first-quarter financial results.</li>
<li>LKQ Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) fell 12.6% to $42.78 after the company reported a first-quarter earnings miss and cut its FY24 outlook.</li>
<li>Simpson Manufacturing Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) dipped 11.7% to $163.40 following weak quarterly earnings.</li>
<li>Jaguar Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares fell 11.2% to $0.1598 after the company filed for a mixed shelf offering of up to $75 million.</li>
<li>Xerox Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>) tumbled 11.1% to $14.60 after the company reported worse-than-expected first-quarter results and reiterated FY24 guidance.</li>
<li>T2 Biosystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTOO#NASDAQ">TTOO</a>) declined 10.4% to $2.83 after gaining around 7% on Monday.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) shares fell 10.1% to $7.13 after the company issued its production and sales performance metrics for the nine months ended 31 March, 2024.</li>
<li>Complete Solaria, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) fell 9.3% to $0.3530 after dipping around 14% on Monday.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) dipped 7.8% to $19.22 after the company&#8217;s reported worse-than-expected first-quarter financial results.</li>
<li>Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) fell 7.1% to $0.77. Phio Pharmaceuticals shares jumped around 33% on Monday after the company announced that its intratumoral injection of murine PH-762 inhibited tumor growth in murine tumor models and may generate memory-specific T cells.</li>
<li>Calix, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) shares fell 4.1% to $28.34 after the company reported mixed first-quarter financial results and issued second-quarter guidance below estimates.</li>
</ul>
Read More: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38379861/bitcoin-surpasses-66-000-akash-network-core-among-top-gainers">Bitcoin Surpasses $66,000; Akash Network, Core Among Top Gainers</a>

AZTR

CALX

CDTX

CHCI

CSLR

CTCX

FCEL

GWAV

HRTX

HSTM

JAGX

KULR

LICN

MESO

MLEC

MSCI

PEGY

PHIO

RNAC

ROKU

SMFL

SMXT

SPCB

SPCE

SPOT

TIRX

TRSG

TTOO

YYGH

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Monness, Crespi, Hardt analyst Jim Chartier downgrades Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) from Buy to Neutral.

Monness, Crespi, Hardt Downgrades Hibbett to Neutral

<h3>Gainers</h3>
<ul>
<li>Cazoo Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CZOO#NYSE">CZOO</a>) shares increased by 83.0% to $9.13 during Tuesday's regular session. The market value of their outstanding shares is at $44.6 million. </li>
<li>Volcon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares moved upwards by 20.24% to $0.28. The company's market cap stands at $5.2 million. </li>
<li>Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) stock rose 18.89% to $86.19. The company's market cap stands at $1.0 billion. </li>
<li>Kidpik (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) shares increased by 17.11% to $3.92. The company's market cap stands at $7.6 million. </li>
<li>17 Education &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YQ#NASDAQ">YQ</a>) shares rose 16.36% to $2.48. The company's market cap stands at $24.1 million. </li>
<li>Groupon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) stock moved upwards by 14.92% to $11.01. The market value of their outstanding shares is at $429.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LKQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) stock declined by 14.3% to $41.93 during Tuesday's regular session. The company's market cap stands at $11.1 billion. The company's, Q1 earnings came out today. </li>
<li>Mynd.ai (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYND#AMEX">MYND</a>) shares declined by 9.1% to $2.8. The company's market cap stands at $127.8 million. </li>
<li>Secoo Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SECO#NASDAQ">SECO</a>) shares declined by 9.01% to $0.39. The market value of their outstanding shares is at $2.7 million. </li>
<li>Singing Machine Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MICS#NASDAQ">MICS</a>) stock decreased by 7.97% to $0.81. The market value of their outstanding shares is at $5.1 million. </li>
<li>Selina Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) stock decreased by 7.08% to $0.06. The market value of their outstanding shares is at $16.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CZOO

GRPN

MICS

MYND

SECO

SLNA

VLCN

11 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

U.S. stocks were higher, with the Nasdaq Composite gaining over 200 points on Tuesday.
Shares of HealthStream, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSTM#NASDAQ">HSTM</a>) rose sharply during Tuesday's session following upbeat <a href="https://www.benzinga.com/quote/HSTM/earnings">quarterly results</a>.
HealthStream posted first-quarter GAAP earnings of 17 cents per share, beating market estimates of 11 cents per share. The company's quarterly sales came in at $72.760 million versus expectations of $71.883 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
HealthStream shares jumped 7.4% to $25.91 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>MMTec, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) shares gained 29% to $2.03.</li>
<li>Hibbett, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) shares climbed 18.4% to $85.85 after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transaction.</li>
<li>SolarMax Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMXT#NASDAQ">SMXT</a>) shares jumped 15.5% to $9.24.</li>
<li>FuelCell Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCEL#NASDAQ">FCEL</a>) rose 15.5% to $0.9295.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) climbed 14.2% to $1.3150.</li>
<li>Virgin Galactic Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NASDAQ">SPCE</a>) gained 14.4% to $0.8603.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) rose 14.2% to $10.30. Critical Metals named Tony Sage as Chief Executive Officer.</li>
<li>Cartesian Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) surged 12.7% to $20.59 after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $39 price target.</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) shares jumped 12.3% to $305.73 following first-quarter financial results.</li>
<li>Heron Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTX#NASDAQ">HRTX</a>) gained 11.6% to $2.89 after Capital One initiated coverage on the stock with an Overweight rating and $6 price target.</li>
<li>Sweetgreen, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) rose 10.3% to $22.42.</li>
<li>Repligen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) climbed 9.6% to $172.59 as life sciences stocks gained following strong earnings from Danaher.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) surged 9.4% to $6.05.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) rose 9.2% to $783.26.</li>
<li>Ryder System, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) climbed 9% to $118.82 following better-than-expected quarterly earnings.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) rose 8.8% to $10.15.</li>
<li>Lifezone Metals Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LZM#NYSE">LZM</a>) gained 8.4% to $7.26.</li>
<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) rose 8.1% to $10.86.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) surged 8.1% to $19.00.</li>
<li>BeiGene, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGNE#NASDAQ">BGNE</a>) rose 7.4% to $140.70 after the European Commission approved Tislelizumab for non-small cell lung cancer across three indications, including first- and second-line use.</li>
<li>Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) rose 7% to $252.49 following better-than-expected first-quarter financial results.</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) gained 6.6% to $172.15.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) shares jumped 6.2% to $62.20.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/04/38376714/wall-streets-most-accurate-analysts-views-on-3-energy-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts&#8217; Views On 3 Energy Stocks With Over 3% Dividend Yields</a>

BGNE

CRML

MARA

RGEN

SMCI

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday

Telsey Advisory Group analyst Joseph Feldman maintains Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) with a Market Perform and raises the price target from $74 to $87.5.

Telsey Advisory Group Maintains Market Perform on Hibbett, Raises Price Target to $87.5

Shares of Hibbett, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a <a href="https://www.benzinga.com/quote/HIBB/news">$1.1 billion transaction</a>.
Hibbett shares jumped 18.4% to $85.83 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares gained 38% to $0.0632 in pre-market trading after falling 10% on Monday</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) gained 34.6% to $6.65 in pre-market trading after the company received FDA approval for ANKTIVA, a first-in-class IL-15 receptor agonist, for BCG-unresponsive non-muscle invasive bladder cancer.</li>
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) gained 31.5% to $0.43 in pre-market trading after the company received a notice of allowance for its U.S. patent application 18/463,612 titled &#8220;Venous Blood Flow Stimulator For Extracorporeal Therapy&#8221;</li>
<li>AGBA Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NASDAQ">AGBA</a>) climbed 24% to $3.10 in pre-market trading on continued upward momentum after the company on Friday announced it entered into a definitive merger agreement with Triller.</li>
<li>HWH International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) rose 15.5% to $1.48 in today's pre-market trading after declining 3% on Monday.</li>
<li>Theriva Biologics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#NYSE">TOVX</a>) gained 15.5% to $0.4748 in pre-market trading after the company announced it will present preclinical data for the potential synergy of VCN-01 and first-line pancreatic cancer chemotherapy regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting.</li>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) shares gained 13.5% to $0.2216 in pre-market trading after the company announced new preclinical data will be presented at the American Society of Gene and Cell Therapy meeting.</li>
<li>China Natural Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHNR#NASDAQ">CHNR</a>) shares gained 12% to $1.12 in pre-market trading.</li>
<li>Cidara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) shares rose 11.9% to $0.5750 in pre-market trading following upbeat quarterly results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Abeona Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) fell 48.1% to $3.82 in pre-market trading after the company announced the FDA issued a Complete Response Letter in response to the company&#8217;s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) fell 31.1% to $0.0870 in pre-market trading after gaining over 8% on Monday.</li>
<li>T2 Biosystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTOO#NASDAQ">TTOO</a>) declined 18.7% to $2.57 in pre-market trading after gaining around 7% on Monday.</li>
<li>Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) fell 16.8% to $0.69 in pre-market trading. Phio Pharmaceuticals shares jumped around 33% on Monday after the company announced that its intratumoral injection of murine PH-762 inhibited tumor growth in murine tumor models and may generate memory-specific T cells.</li>
<li>Calix, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) shares fell 16.8% to $24.60 in pre-market trading after the company reported mixed first-quarter financial results and issued second-quarter guidance below estimates.</li>
<li>Complete Solaria, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) fell 13.7% to $0.3360 in pre-market trading after dipping around 14% on Monday.</li>
<li>Tungray Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) shares declined 13.7% to $6.37 in pre-market trading after gaining 24% on Monday.</li>
<li>Jaguar Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares fell 12.1% to $0.1581 in pre-market trading after the company filed for a mixed shelf offering of up to $75 million.</li>
<li>YY Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYGH#NASDAQ">YYGH</a>) fell 13.8% to $2.50 pre-market trading after tumbling over 27% on Monday. The company, last week, priced its IPO at $4 per share.</li>
<li>Cadence Design Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) fell 5.7% to $268.91 pre-market trading after the company issued second-quarter guidance below estimates.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38370420/general-motors-tesla-and-3-stocks-to-watch-heading-into-tuesday">General Motors, Tesla And 3 Stocks To Watch Heading Into Tuesday</a>

AGBA

CDNS

CHNR

IBRX

NUWE

TOVX

Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Hibbett (NASDAQ:<a href="https://investorplace.com/stock-quotes/hibb-stock-quote/">HIBB</a>) just reported results for the first quarter of 2025.<ul><li>Hibbett reported earnings per share of $2.67. This was above the analyst estimate for EPS of $2.63.</li><li>The company reported revenue of $447.16 million.</li><li>This was 1.49% worse than the analyst estimate for revenue of $453.91 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/06/hibb-stock-earnings-hibbett-for-q1-of-2025/">HIBB Stock Earnings: Hibbett Beats EPS, Misses Revenue for Q1 2025</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

HIBB Stock Earnings: Hibbett Beats EPS, Misses Revenue for Q1 2025

Analyst Justin Kleber from Robert W. Baird maintained a Hold rating on Hibbett Sports (HIBB – Research Report) and keeping the price target at $87....

Hibbett Sports: Strong Margins Amid Market Challenges Lead to Hold Rating

JD Sports: Building A Global Giant With Hibbett

Hibbett Sports (HIBB) has disclosed a new risk, in the Litigation & Legal Liabilities category. Hibbett Sports faces substantial legal risk due to ...

Hibbett Sports Braces for Shareholder Litigation Risks Amidst Merger Turmoil

Catalyst Watch: Netflix, Taiwan Semi, Amazon, and HashiCorp are in the spotlight

Back-to-school spending likely to remain unchanged this year

VCR: Consumer Discretionary Sector Dashboard For July

In March, while placing sporting goods company Hibbett ($HIBB) under the spotlight, I wrote that despite a challenging retail market, it was a "com...

Spotlight on Hibbett (HIBB): The Risk and Reward of JD Sports Acquisition

Hibbett shareholders approve the sale to JD Sports

Hibbett Sports (HIBB) just unveiled an update. Upon the completion of a merger, a company repaid all outstanding debts, transformed common stock in...

Hibbett Sports Announces Merger and Major Corporate Changes

AAPL

ALLY

AMZN

ARDT

ASML

AVGO

BGFV

BKNG

BSFC

BYDDF

CIFR

DELL

FDIS

HELE

HLVX

HOOD

INDV

JBHT

JDDSF

LCID

LRTX

MODG

NFLX

PINS

PSIX

RDDT

RSPD

RVMD

SBUX

SCHW

SNAP

SOUN

TSLA

TWFG

ZAPP

Press Releases

Kuehn Law Encourages HIBB, CRGY, DCPH, and HCP Investors to Contact Law Firm

SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate HMST, AA, HIBB, HRT

Hibbett Reports First Quarter Fiscal 2025 Results

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, ALLG, HIBB on Behalf of Shareholders

HIBBETT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hibbett, Inc. - HIBB

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, HIBB, SBOW, MRO on Behalf of Shareholders

URGENT STOCKHOLDER REMINDER: The M&A Class Action Firm Investigates Merger and Imminent Vote on July 19, 2024, of Hibbett, Inc - HIBB

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HIBB, SBOW, FREE on Behalf of Shareholders

Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Hibbett Inc Com

Hibbett Inc Com (HIBB) Forecast

Hibbett Inc Com (NASDAQ:HIBB) Stock, Quote.Headers.trade-ideas